Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombogenicity of Qlaira versus Microgynon 30
2010-018590-38Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in contraception comparing Qlaira arm with Microgynon 30 arm (2 arms). Primary endpoints: Thrombin generation-based APC resistance and Sex hormone-binding globulin. Started Feb 2010; status: active.
02
Drugs
estradiol valerate + dienogestethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2010-018590-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018590-38.